JP2006036796A5 - - Google Patents

Download PDF

Info

Publication number
JP2006036796A5
JP2006036796A5 JP2005305080A JP2005305080A JP2006036796A5 JP 2006036796 A5 JP2006036796 A5 JP 2006036796A5 JP 2005305080 A JP2005305080 A JP 2005305080A JP 2005305080 A JP2005305080 A JP 2005305080A JP 2006036796 A5 JP2006036796 A5 JP 2006036796A5
Authority
JP
Japan
Prior art keywords
alkyl
hydrogen
substituted
cancer
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005305080A
Other languages
English (en)
Japanese (ja)
Other versions
JP4699171B2 (ja
JP2006036796A (ja
Filing date
Publication date
Priority claimed from US10/224,979 external-priority patent/US6800655B2/en
Application filed filed Critical
Publication of JP2006036796A publication Critical patent/JP2006036796A/ja
Publication of JP2006036796A5 publication Critical patent/JP2006036796A5/ja
Application granted granted Critical
Publication of JP4699171B2 publication Critical patent/JP4699171B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2005305080A 2002-08-20 2005-10-19 化学療法薬および化学防御薬としてのインドール−3−カルビノール代謝物の類似物 Expired - Fee Related JP4699171B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/224,979 US6800655B2 (en) 2002-08-20 2002-08-20 Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
US10/224,979 2002-08-20

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2004531045A Division JP4764629B2 (ja) 2002-08-20 2003-08-15 化学療法薬および化学防御薬としてのインドール−3−カルビノール代謝物の類似物

Publications (3)

Publication Number Publication Date
JP2006036796A JP2006036796A (ja) 2006-02-09
JP2006036796A5 true JP2006036796A5 (US07928230-20110419-C00107.png) 2006-08-10
JP4699171B2 JP4699171B2 (ja) 2011-06-08

Family

ID=31946289

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2004531045A Expired - Fee Related JP4764629B2 (ja) 2002-08-20 2003-08-15 化学療法薬および化学防御薬としてのインドール−3−カルビノール代謝物の類似物
JP2005305080A Expired - Fee Related JP4699171B2 (ja) 2002-08-20 2005-10-19 化学療法薬および化学防御薬としてのインドール−3−カルビノール代謝物の類似物
JP2010139927A Expired - Fee Related JP5599236B2 (ja) 2002-08-20 2010-06-18 化学療法薬および化学防御薬としてのインドール−3−カルビノール代謝物の類似物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2004531045A Expired - Fee Related JP4764629B2 (ja) 2002-08-20 2003-08-15 化学療法薬および化学防御薬としてのインドール−3−カルビノール代謝物の類似物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010139927A Expired - Fee Related JP5599236B2 (ja) 2002-08-20 2010-06-18 化学療法薬および化学防御薬としてのインドール−3−カルビノール代謝物の類似物

Country Status (8)

Country Link
US (4) US6800655B2 (US07928230-20110419-C00107.png)
EP (2) EP1623985B1 (US07928230-20110419-C00107.png)
JP (3) JP4764629B2 (US07928230-20110419-C00107.png)
AT (1) ATE411317T1 (US07928230-20110419-C00107.png)
AU (1) AU2003263878A1 (US07928230-20110419-C00107.png)
CA (1) CA2496203C (US07928230-20110419-C00107.png)
DE (1) DE60324155D1 (US07928230-20110419-C00107.png)
WO (1) WO2004018475A2 (US07928230-20110419-C00107.png)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6800655B2 (en) * 2002-08-20 2004-10-05 Sri International Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
WO2005107747A2 (en) * 2004-05-06 2005-11-17 Bioresponse, Llc Diindolymethane formulations for the treatment of leiomyomas
US20060100264A1 (en) * 2004-11-06 2006-05-11 Bjeldanes Leonard F 3,3'-Diindolylmethane immune activating compositions
EP1838303B1 (en) 2004-12-30 2011-02-09 Bioresponse LLC Use of diindolylmethane-related indoles for the treatment and prevention of respiratory syncytial virus associates conditions
AU2006207321B2 (en) 2005-01-21 2012-09-06 Astex Therapeutics Limited Pharmaceutical compounds
JP2008545663A (ja) * 2005-05-27 2008-12-18 クイーンズ ユニバーシティ アット キングストン タンパク質フォールディング障害の治療
CN1807413B (zh) * 2005-09-28 2010-05-05 中国医学科学院医药生物技术研究所 咔唑磺酰胺衍生物及其制备方法
RU2435764C2 (ru) 2006-04-18 2011-12-10 Ниппон Кемифар Ко., Лтд. АГЕНТ, АКТИВИРУЮЩИЙ РЕЦЕПТОР, АКТИВИРУЕМЫЙ ПРОЛИФЕРАТОРАМИ ПЕРОКСИСОМ δ
JP5528806B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
WO2008044045A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
BRPI0717753B1 (pt) * 2006-10-27 2022-04-12 Bioresponse, Llc Uso de uma composição compreendendo 50-250 mg de um ou mais indóis relacionados com dim e um ou mais agentes anti-protozoários, e, composição
WO2008144263A1 (en) * 2007-05-18 2008-11-27 The Ohio State University Research Foundation Potent indole-3-carbinol-derived antitumor agents
US20100292316A1 (en) * 2007-07-18 2010-11-18 Research Development Foundation Improved therapeutic methods and compositions comprising chroman ring compounds
NZ588612A (en) * 2008-04-15 2012-08-31 Nippon Chemiphar Co Benzothiophen derivatives as activators of peroxisome proliferator activated receptor (PPAR)
WO2010033198A2 (en) * 2008-09-17 2010-03-25 Sri International Analogs of indole-3-carbinol and their use as agents against infection
KR101477613B1 (ko) * 2009-03-31 2014-12-30 롬엔드하스전자재료코리아유한회사 신규한 유기 전자재료용 화합물 및 이를 포함하는 유기 전자 소자
WO2010118339A2 (en) * 2009-04-09 2010-10-14 University Of Kansas Formulations of indole-3-carbinol derived antitumor agents with increased oral bioavailability
MX2012001932A (es) * 2009-08-14 2012-03-14 Nippon Chemiphar Co Uso de ligandos ppar delta para el tratamiento o prevencion de enfermedades relacionadas con metabolismo/produccion de inflamacion o energia.
US8153680B2 (en) * 2009-08-25 2012-04-10 The Ohio State University Research Foundation Alkyl indole-3-carbinol-derived antitumor agents
DE102009052428A1 (de) * 2009-11-10 2011-05-12 Merck Patent Gmbh Verbindung für elektronische Vorrichtungen
CN102917707A (zh) * 2010-05-06 2013-02-06 默沙东公司 可用作faah调节剂的氮杂吲哚衍生物
CA2827214C (en) * 2011-04-01 2017-07-18 Sri International Lipoxygenase inhibitors
WO2015042170A1 (en) 2013-09-17 2015-03-26 Wayne State University Compositions and uses of combinations of dim-related indoles and selected anti-androgen compounds
CN104030964B (zh) * 2014-06-05 2016-06-29 天津科技大学 双吲哚类化合物及合成方法
US9969686B2 (en) * 2014-08-05 2018-05-15 Wisconsin Alumni Research Foundation Synthesis of diindolylmethanes and indolo[3,2-b]carbazoles, compounds formed thereby, and pharmaceutical compositions containing them
EP3280398A4 (en) 2015-04-10 2018-12-12 Bioresponse LLC Self-emulsifying formulations of dim-related indoles
CA3030582A1 (en) * 2015-07-22 2017-01-26 The Royal Institution For The Advancement Of Learning/Mcgill University Compounds and uses thereof in the treatment of cancers and other medical conditions
CN105218552B (zh) * 2015-09-30 2018-02-27 中国人民解放军军事医学科学院野战输血研究所 一种取代苯基二氢吲哚咔唑衍生物及其制备方法与应用
CN110698654B (zh) * 2018-07-10 2021-04-02 中国科学院长春应用化学研究所 基于三聚吲哚的超支化共轭聚电解质及其制备方法和用途

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1282451B (de) * 1965-09-01 1968-11-07 Kalle Ag Lichtempfindliche Schicht und Verfahren zur Herstellung fixierter Bilder
US4636820A (en) * 1980-03-06 1987-01-13 The Hilton-Davis Chemical Compositions, process and systems
EP0266310B1 (de) * 1986-10-28 2001-12-05 Ciba SC Holding AG Chromogene Phthalide
GB8713564D0 (en) 1987-06-10 1987-07-15 Kong Y C Synthesis
NZ227850A (en) * 1988-02-10 1991-11-26 Hoffmann La Roche Indole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
US5116978A (en) * 1989-03-08 1992-05-26 Appleton Papers Inc. Process for bis(indolyl)ethylene synthesis
US5086171A (en) * 1989-03-08 1992-02-04 Appleton Papers Inc. Bis-(indolyl)ethylenes
JP3038064B2 (ja) * 1991-10-07 2000-05-08 日清製粉株式会社 インドール誘導体およびこれを有効成分とする抗潰瘍薬
DE59207620D1 (de) * 1991-10-30 1997-01-16 Ciba Geigy Ag NIR-Farbstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung
US5206377A (en) * 1991-12-05 1993-04-27 Whitby Research, Inc. Compounds useful as antiproliferative agents
US5407102A (en) * 1994-02-15 1995-04-18 Freudinger; Mark J. Apparatus for dispensing a quantity of flowable material
US5948808A (en) * 1997-03-07 1999-09-07 The Texas A&M University System Indole-3-carbinol, diindolylmethane and substituted analogs as antiestrogens
US5942340A (en) * 1997-10-02 1999-08-24 Xerox Corporation Indolocarbazole electroluminescent devices
US5843607A (en) * 1997-10-02 1998-12-01 Xerox Corporation Indolocarbazole photoconductors
BR9911017A (pt) * 1998-05-04 2001-02-06 Asta Medica Ag Derivados de indol e seu emprego para o tratamento de doenças malignas e outras, que se baseiam na proliferação de células patológicas
DE69920455T2 (de) * 1998-07-08 2005-01-20 Harbor Branch Oceanographic Institution Inc., Fort Pierce Bis-indolederivate und ihre verwendung als entzündungshemmende mittel
IT1317926B1 (it) 2000-11-03 2003-07-15 Sigma Tau Ind Farmaceuti Derivati triciclici dell'indolo ad attivita' antiangiogenica.
IT1317925B1 (it) 2000-11-03 2003-07-15 Sigma Tau Ind Farmaceuti Bis-eterocicli ad attivita' antitumorale e chemosensibilizzante.
JP2003346530A (ja) * 2002-05-23 2003-12-05 Nippon Sheet Glass Co Ltd 面状光源装置および画像読み取り装置
US6800655B2 (en) * 2002-08-20 2004-10-05 Sri International Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents

Similar Documents

Publication Publication Date Title
JP2006036796A5 (US07928230-20110419-C00107.png)
JP2006500379A5 (US07928230-20110419-C00107.png)
CA2496203A1 (en) Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
ES2394472T3 (es) Derivados de quinazolín-oxima como inhibidores de hsp90
US7482343B2 (en) Compounds, methods and compositions
ES2487534T3 (es) Derivados de 2,4 di[(hetero)-arilamino]-pirimidina como inhibidores de Zap-70 y/o SYK
JP2009502809A5 (US07928230-20110419-C00107.png)
JP5607241B2 (ja) 新規ピリミジン誘導体
US20040082567A1 (en) Compounds, compositions, and methods
CN101784552A (zh) 6-环氨基-3-(哒嗪-4-基)咪唑并[1,2-b]哒嗪的衍生物、其制备和其治疗学用途
CA2501547A1 (en) Substituted indoles and their use as hcv inhibitors
CN104302628A (zh) 羧酸化合物
US20060004073A1 (en) Compounds, compositions, and methods
CN101775059A (zh) 新的甘草次酸衍生物、其制备方法及其医药用途
JP6522007B2 (ja) 癌及びウイルス感染症に対する使用のための脂質合成の複素環式モジュレータ
WO2009002808A2 (en) Quinazolinone compounds and methods of use thereof
JP2022549923A (ja) Nヘテロ五員環含有カプシドタンパク質集合阻害剤の結晶形及びその使用
JPH0625232A (ja) 置換インドールおよびベンズイミダゾール誘導体
JP7036332B2 (ja) キノリン又はキナゾリン化合物及びその応用
WO2006106721A1 (ja) チロシンキナーゼ阻害作用を有するピリミジン誘導体
CN114195777A (zh) 新型fxr小分子激动剂制备及其用途
RU2726456C1 (ru) Ингибитор вируса гепатита В (ВГВ)
Giang et al. Design, Synthesis and Cytotoxic Evaluation of 4-Anilinoquinazoline–triazole–AZT Hybrids as Anticancer Agents
CN104311621A (zh) D环修饰的甾体β-内酰胺类化合物、其制备方法及其应用
JP2005154347A (ja) カルバゾール誘導体またはその塩を有効成分とするインテグラーゼ阻害剤および抗レトロウイルス剤